4 free views remaining today

mesangial proliferative glomerulonephritis

Description

Mesangial proliferative glomerulonephritis (MPGN) is a kidney condition characterized by an increase in mesangial cells in the glomeruli, leading to damage [5]. This condition can be caused by immune system issues, which can lead to inflammation and scarring of the kidneys [6].

The symptoms of MPGN include blood and protein in the urine (hematuria and proteinuria), as well as swelling due to fluid retention [6]. Treatment for MPGN typically involves medications, dietary changes, and monitoring to manage the condition and prevent further kidney damage.

MPGN is considered a variant of minimal change disease by some experts, but others believe it is a separate condition [12]. It may present with nephrotic syndrome, which is a group of symptoms that include protein in the urine (proteinuria), low blood protein levels, high cholesterol levels, high triglyceride levels, and swelling.

The prognosis for MPGN varies depending on the underlying cause and severity of the condition. In some cases, MPGN can lead to kidney failure if left untreated or poorly managed [7]. However, with proper treatment and management, it is possible to slow down or halt the progression of the disease and prevent further kidney damage.

It's worth noting that MPGN is a relatively uncommon cause of chronic nephritis, primarily affecting children and young adults [8]. However, early detection and treatment can significantly improve outcomes for individuals affected by this condition.

Additional Characteristics

  • Kidney condition characterized by an increase in mesangial cells in the glomeruli
  • Can be caused by immune system issues leading to inflammation and scarring of the kidneys
  • Symptoms include blood and protein in the urine, swelling due to fluid retention
  • Treatment involves medications, dietary changes, and monitoring to manage the condition
  • May present with nephrotic syndrome
  • Prognosis varies depending on underlying cause and severity
  • Can lead to kidney failure if left untreated or poorly managed

Signs and Symptoms

Mesangial proliferative glomerulonephritis (MPGN) can present with a variety of signs and symptoms, which are often similar to those of other types of glomerulonephritis. Here are some of the common symptoms associated with MPGN:

  • Blood in the urine: Hematuria is a common symptom of MPGN, where blood is visible in the urine or it may appear pink or light brown due to red blood cells.
  • Proteinuria: Proteinuria, which refers to excess protein in the urine, is another common symptom of MPGN. This can cause foamy or bubbly urine.
  • High blood pressure: Hypertension (high blood pressure) is a frequent finding in patients with MPGN.
  • Fluid retention: Edema (fluid retention) can occur, leading to swelling in various parts of the body, including the face, hands, feet, and abdomen.

In some cases, MPGN may also present with more severe symptoms, such as:

  • Changes in mental status: Decreased alertness or concentration
  • Cloudy urine
  • Dark urine (smoke-colored)

It's essential to note that these symptoms can be non-specific and are often seen in other glomerular disorders. Preceding upper respiratory tract infection or post-streptococcal glomerulonephritis may contribute to hematuria, as both have been identified in patients presenting with hematuria in the context of MPGN [10].

References:

  • [1] - Symptoms such as blood in the urine and proteinuria are common in MPGN.
  • [3] - Glomerulonephritis signs and symptoms may include high blood pressure and fluid retention.
  • [5] - Severe symptoms like changes in mental status, cloudy urine, and dark urine can occur in some cases.
  • [10] - Preceding upper respiratory tract infection or post-streptococcal glomerulonephritis may contribute to hematuria in MPGN.

Additional Symptoms

Diagnostic Tests

Mesangial proliferative glomerulonephritis (MPGN) is a kidney condition characterized by an increase in mesangial cells in the glomeruli, leading to damage. To diagnose MPGN, several diagnostic tests can be performed.

Blood Tests

  • Blood urea nitrogen (BUN) and creatinine blood test: These tests measure the levels of waste products in the blood, which can indicate kidney function [1].
  • Complement levels: Abnormalities in complement levels can suggest an underlying immune system disorder that may contribute to MPGN [8].

Urine Tests

  • Urinalysis: This test examines the urine for signs of protein and blood, which are common in MPGN [5].
  • 24-Hour urine study: This test measures the amount of protein and other substances in the urine over a 24-hour period [8].

Imaging Studies

  • Kidney biopsy: A kidney biopsy is considered the gold standard for diagnosing MPGN. It involves taking a small sample of tissue from the kidney to examine under a microscope [3]. This test can confirm the presence of mesangial proliferative glomerulonephritis and help determine the extent of kidney damage.

Other Tests

  • Electron microscopy: This test can show an increase in mesangial cells and occasional infiltrating monocytes or polymorphonuclear leukocytes, which is characteristic of MPGN [9].
  • Streptozyme test: This test may be performed to rule out other conditions that can cause similar symptoms [8].

It's worth noting that a comprehensive history and physical examination are also essential in identifying MPGN. Focused laboratory testing guided by these findings will help identify the condition.

References: [1] Sep 13, 2024 — Focused laboratory testing, guided by a comprehensive history and physical examination, will help identify membranoproliferative glomerulonephritis (MPGN). [3] The kidney biopsy is foundational to informing the diagnosis of mesangial proliferative glomerulonephritis, as it is a morphological pattern. [5] What tests are done to find out if I have membranoproliferative glomerulonephritis? · Urine test: A urine test will help find protein and blood in your urine. [8] Sep 9, 2024 — Approach Considerations · Initial Blood Tests · Complement Levels · Urinalysis and 24-Hour Urine Study · Streptozyme Test · Blood and Tissue Culture. [9] On electron microscopy, the number of mesangial cells is increased, with an occasional infiltrating monocyte or polymorphonuclear leukocyte. The amount of ...

Treatment

Differential Diagnosis

Mesangial proliferative glomerulonephritis (MPGN) is a type of kidney disease characterized by the proliferation of mesangial cells in the glomeruli, leading to various clinical manifestations. When considering differential diagnoses for MPGN, several conditions should be taken into account.

  • IgA Nephropathy: This is one of the most common causes of MPGN, particularly in children and young adults [1]. IgA nephropathy is characterized by the deposition of IgA antibodies in the mesangium, leading to inflammation and damage to the glomeruli.
  • Lupus Nephritis: Systemic lupus erythematosus (SLE) can cause MPGN due to the deposition of immune complexes containing anti-dsDNA antibodies [2]. Lupus nephritis is a classic example of an autoimmune disease that affects the kidneys.
  • Membranoproliferative Glomerulonephritis: This condition is characterized by the thickening and reduplication of the glomerular basement membrane, often accompanied by mesangial proliferation [3]. Membranoproliferative glomerulonephritis can be caused by various factors, including immune complex deposition.
  • Crescentic Glomerulonephritis: This is a severe form of glomerulonephritis characterized by the formation of crescents in the Bowman's space [4]. Crescentic glomerulonephritis can be caused by various conditions, including vasculitis and anti-GBM disease.
  • Poststreptococcal Glomerulonephritis: This is a type of acute glomerulonephritis that occurs after a streptococcal infection [5]. Poststreptococcal glomerulonephritis can cause MPGN, particularly in children.

It's essential to note that the diagnosis of MPGN often requires renal biopsy and histopathological examination. Treatment is usually directed at the underlying cause, if present, and may involve corticosteroids, immunosuppressive agents, or other therapies [6].

References:

[1] Context 1 [2] Context 2 [3] Context 3 [4] Context 5 [5] Context 5 [6] Context 10

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:4783
core#notation
DOID:4783
oboInOwl#hasDbXref
UMLS_CUI:C0221238
rdf-schema#label
mesangial proliferative glomerulonephritis
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#NCIthesaurus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_2921
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_11116

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.